Kazia Therapeutics (KZIA) Assets Average (2009 - 2025)

Kazia Therapeutics (KZIA) has 14 years of Assets Average data on file, last reported at $25.3 million in Q4 2025.

• In Q4 2025, Assets Average rose 94.96% year-over-year to $25.3 million; the TTM figure through Dec 2025 stood at $25.3 million (up 94.96% YoY), while the FY2025 annual figure was $9.1 million, down 45.13% from the prior year.
• Assets Average improved to $25.3 million in Q4 2025, from $7.8 million in the prior quarter.
• Across five years, Assets Average topped out at $70.6 million in Q2 2021 and bottomed at $7.8 million in Q2 2025.
• A 5-year average of $28.6 million and a median of $18.5 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average soared 384.77% — and 2023, when it slumped 72.87%.
• Year by year, Assets Average stood at $70.6 million in 2021, then plunged by 69.77% to $21.3 million in 2022, then fell by 18.82% to $17.3 million in 2023, then decreased by 25.13% to $13.0 million in 2024, then surged by 94.96% to $25.3 million in 2025.
• The last three Assets Average figures came in at $25.3 million (Q4 2025), $7.8 million (Q2 2025), and $13.0 million (Q4 2024), per Business Quant data.

Peer Comparison